This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Stock Market News for November 21, 2016
by Zacks Equity Research
Rising rate hike possibilities boosted the dollar to its best settlement in 13 years, which in turn dragged the benchmarks into the red on Friday.
Is Immunotherapy the Next Hot Industry for Biotech Stock Investors?
by Eric Dutram
In this edition of the Dutram Report, Eric Dutram talks with Brad Loncar, the CEO of Loncar Investments who specializes in the world of immunotherapy. This approach is revolutionizing the cancer treatment market, and we get to the bottom of this emerging technology in the podcast so that investors can better understand why this market may deserve a closer look.
The Zacks Analyst Blog Highlights: UnitedHealth Group, Merck, JPMorgan Chase, Goldman Sachs Group and Cisco Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth Group, Merck, JPMorgan Chase, Goldman Sachs Group and Cisco Systems
The Zacks Analyst Blog Highlights: Merck, DISH Network, Pioneer Natural Resources, Johnson Controls and Boston Properties
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, DISH Network, Pioneer Natural Resources, Johnson Controls and Boston Properties
Zacks Industry Outlook Highlights: Bristol-Myers, Biogen, Merck, Celgene and ARIAD Pharmaceuticals
by Zacks Equity Research
Zacks Industry Outlook Highlights: Bristol-Myers, Biogen, Merck, Celgene and ARIAD Pharmaceuticals
Stock Market News for October 19, 2016
by Zacks Equity Research
Upbeat earnings results led the benchmarks to close in the green on Tuesday
Stock Market News for August 09, 2016
by Zacks Equity Research
Despite strong crude rally, major benchmarks closed in the red on Monday on the back of declines in healthcare stocks
BLS Reports Robust July Jobs: 255K, 4.9% Unemployment
by Mark Vickery
Also, May's paltry 11K jobs was more than doubled to 24K, and even June's strong 287K rose another 5000 jobs to 292K.
Stock Market News for April 07, 2016
by Zacks Equity Research
Benchmarks closed in the green on Wednesday following gains in biotech and energy stocks
Stock Market News for March 22, 2012
by Zacks Equity Research
Gains in healthcare and telecom stocks helped the benchmarks end marginally higher on Monday.
CDXS and LOGI are Aggressive Growth Stocks
by Brian Bolan
Biotech supply chain and computer peripherals are the focus